Top compounds associated with response to STK36


Feature Type Standardized
Nominal ANOVA
mRNA nintedanib CTRPv2 pan-cancer AAC 0.018 0.7
mRNA VU0155056 CTRPv2 pan-cancer AAC 0.018 0.7
mRNA canertinib CTRPv2 pan-cancer AAC -0.017 0.7
mRNA QL-XII-47 GDSC1000 pan-cancer AAC 0.015 0.7
mRNA Vandetanib CCLE pan-cancer AAC -0.021 0.7
mRNA BRD6340 CTRPv2 pan-cancer AAC 0.017 0.7
mRNA Axitinib GDSC1000 pan-cancer AAC 0.017 0.7
mRNA Bexarotene CTRPv2 pan-cancer AAC 0.017 0.7
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.017 0.7
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.014 0.7
Download CSV